UBS AM’s C4 Therapeutics CCCC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-39,287	Closed	-$123K	–	2609
2023 Q2	$123K	Hold	39,287	–	–	﹤0.01%	2624
2023 Q1	$123K	Buy	39,287 +9,994	+34%	+$31.4K	﹤0.01%	2624
2022 Q4	$173K	Buy	+29,293	New	+$173K	﹤0.01%	2462